Glassman Wealth Services »

Intensity Therapeutics shares owned by Glassman Wealth Services

Quarter-by-quarter ownership of Intensity Therapeutics (INTS) shares owned by Glassman Wealth Services from 13F filings

Historical chart of Glassman Wealth Services investment in Intensity Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intensity Therapeutics held by Glassman Wealth Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intensity Therapeutics by Glassman Wealth Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7k 200 8.57
2023-09-30 $794 200 3.97
2023-06-30 $1.2k 200 5.96

More positions owned by Glassman Wealth Services

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Schwab Strategic Tr Schwab Fdt Us Lg (FNDX)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Dimensional Etf Trust World Ex Us Core (DFAX)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Rus 1000 Etf (IWB)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Mcp Etf (IJH)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)

View all positions for Glassman Wealth Services

Top funds holding Intensity Therapeutics

Sapient Capital
Vanguard Group
Brown Advisory Holdings Incorporated
Sigma Planning
Geode Capital Management
Mesirow Financial Investment Management International Equity
One Charles Private Wealth Services
Sentinus
Lakeview Capital Partners
Qube Research & Technologies
BlackRock
Commonwealth Equity Services
Jpmorgan Chase & Co
Tower Research Capital
UBS Group

View all funds holding Intensity Therapeutics